Possible rivaroxaban failure during the postpartum period

Keyphrases

• Rivaroxaban 100%
• Postpartum Period 100%
• Pulmonary Embolism 80%
• Deep Vein Thrombosis 60%
• Direct Oral Anticoagulants 60%
• Special Populations 40%
• Pharmacokinetic Changes 40%
• Pharmacokinetics 20%
• Risk Reduction 20%
• Pharmacodynamics 20%
• Emergency Department 20%
• Factor Xa Inhibitors 20%
• Enoxaparin 20%
• Warfarin 20%
• Anticoagulants 20%
• Thrombosis 20%
• Hypercoagulability 20%
• Clinical Situation 20%
• Drug Exposure 20%
• Anticoagulant Therapy 20%
• Pharmacist-managed 20%
• Close Follow-up 20%
• Potential Failure 20%
• Heparin Infusion 20%
• Embolization 20%
• Precipitating Cause 20%
• Drug Clearance 20%
• First Case Report 20%
• Postpartum Women 20%
• Oral Anticoagulant Therapy 20%
• Anticoagulation Management Service 20%
• Postpartum Patient 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Rivaroxaban 100%
• Anticoagulant Agent 80%
• Lung Embolism 80%
• Deep Vein Thrombosis 60%
• Pharmacokinetics 60%
• Pharmacodynamics 20%
• Heparin 20%
• Enoxaparin 20%
• Warfarin 20%
• Blood Clotting Factor 10a Inhibitor 20%
• Thrombosis 20%
• Hypercoagulability 20%
• Anticoagulation Therapy 20%
• Embolism 20%